Grow your business safely with CL PHARMA

All the information you need about CL PHARMA to develop and secure your business in France

C HOME > CORPORATES > CL PHARMA > BALANCE SHEET ( 2022-11-24)

THE LIST OF BALANCE SHEET : CL PHARMA

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2022-11-24 Partially confidential 2022-03-31 Complete
2022-01-21 Partially confidential 2021-03-31 Complete
NameCL PHARMA
Siren884949991
Closing2022-03-31
Registry code 6852
Registration number 11815
Management number2020D00604
Activity code 6430Z
Closing date n-12021-03-31
Duration Fiscal year 12
Duration Fiscal year n-109
Filing date2022-11-24
Modification00 Annual accounts entered without anomaly
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPartially confidential
Address68210 DANNEMARIE
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
AB Establishment Expenses 6 001.00 2 831.00 3 170.00 6 001.00
BJ TOTAL (I) 1 828 401.00 2 831.00 1 825 570.00 1 828 401.00
BX Customers and related accounts 70 000.00 70 000.00 70 000.00
CF Cash and cash equivalents 50 178.00 50 178.00 50 178.00
CJ TOTAL (II) 120 178.00 120 178.00 120 178.00
CO Grand total (0 to V) 1 948 579.00 2 831.00 1 945 748.00 1 948 579.00
CU Other investments 1 822 400.00 1 822 400.00 1 822 400.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 647 400.00 647 400.00 647 400.00
DH Retained earnings -7 278.00 -7 278.00
DI RESULTS FOR THE YEAR (Profit or Loss) 144 646.00 -7 278.00 144 646.00
DL TOTAL (I) 784 768.00 640 122.00 784 768.00
DU Loans and Debts from Credit Institutions (3) 1 147 801.00 1 172 000.00 1 147 801.00
DV Miscellaneous Loans and Financial Debts (4) 2 600.00 16 600.00 2 600.00
DX Trade payables and related accounts 1 200.00 1 200.00
DY Tax and social security liabilities 9 379.00 9 379.00
EC TOTAL (IV) 1 160 980.00 1 188 600.00 1 160 980.00
EE Grand total (I to V) 1 945 748.00 1 828 722.00 1 945 748.00
EG Accrued income and payables due within one year 83 657.00 24 199.00 83 657.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 1 828 401.00 1 828 401.00
CZ ACQUISITIONS: Establishment, Development, or Research Expenses 6 001.00 6 001.00
I3 DECREASES Total Financial Fixed Assets 1 822 400.00
I4 DECREASES Grand Total 1 828 401.00
IN DECREASES Start-up, development, or research expenses 6 001.00
LQ ACQUISITIONS Total Financial Fixed Assets 1 822 400.00 1 822 400.00
6 - Depreciation Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
0N DEPRECIATION Grand Total 829.00 2 002.00 829.00
CY DEPRECIATION Start-up, development, or research expenses 829.00 2 002.00 829.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
8B Suppliers and Related Accounts 1 200.00 1 200.00 1 200.00
8E Income Taxes 9 379.00 9 379.00 9 379.00
UX Other trade receivables 70 000.00 70 000.00 70 000.00
VH Loans with a maturity of more than one year at origin 1 147 801.00 73 078.00 299 653.00 1 147 801.00
VI Group and Associates 2 600.00 2 600.00
VK Loans repaid during the year 24 199.00 24 199.00
VT TOTAL – STATEMENT OF RECEIVABLES 70 000.00 70 000.00 70 000.00
VY TOTAL – STATEMENT OF LIABILITIES 1 160 980.00 83 657.00 299 653.00 1 160 980.00
11 - Earnings appropriation & miscellaneous informationAmount for year NAmount for year N-1Amount 1 to 5 yearsAmount more than 5 years
9Z Other taxes, duties, and similar payments 45.00 45.00
SS Intermediary remuneration and fees (excluding retrocessions) 1 700.00 1 700.00
ST Other accounts 475.00 525.00 475.00
YX Total of the account corresponding to line FX of table no. 2052 45.00 45.00
ZJ Total of the item corresponding to line FW of table no. 2052 2 175.00 525.00 2 175.00

all companies in France

Complete and comprehensive database.